<DOC>
	<DOC>NCT00595621</DOC>
	<brief_summary>Investigate the safety and efficacy of multi-channel gastric electrical stimulation in the treatment of patients with severe diabetic gastroparesis refractory to standard therapy.</brief_summary>
	<brief_title>Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis</brief_title>
	<detailed_description>Evaluation of severe symptom control of nausea, vomiting, postprandial fullness, early satiety, bloating and discomfort related to drug refractory gastroparesis present as a GI complication in diabetic patients. External gastric pacemaker system will be placed at the same time of implantation of Enterra (internal gastric stimulator-permanent device) to assess symptoms, quality of life improvement and investigate the changes in gastric emptying time in DM gastroparetics.</detailed_description>
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>Severe nausea and vomiting for at least 6 months Documented delayed gastric emptying Failed extensive medical treatment Previous gastric surgery Pregnancy or planned pregnancy Primary eating or swallowing disorders Scheduled or planned MRI testing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>